We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,055 hedge funds and large institutions have $51.5B invested in Thermo Fisher Scientific in 2016 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 384 increasing their positions, 421 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 38

34% more call options, than puts

Call options by funds: $233M | Put options by funds: $174M

5% more capital invested

Capital invested by funds: $48.9B → $51.5B (+$2.6B)

3% more funds holding

Funds holding: 1,0241,055 (+31)

1% more funds holding in top 10

Funds holding in top 10: 7778 (+1)

9% less repeat investments, than reductions

Existing positions increased: 384 | Existing positions reduced: 421

2.57% less ownership

Funds ownership: 91.36%88.79% (-2.6%)

Holders
1,055
Holders Change
+31
Holders Change %
+3.03%
% of All Funds
28.15%
Holding in Top 10
78
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+1.3%
% of All Funds
2.08%
New
79
Increased
384
Reduced
421
Closed
38
Calls
$233M
Puts
$174M
Net Calls
+$59M
Net Calls Change
+$99.8M
Name Holding Trade Value Shares
Change
Change in
Stake
N
326
Nuveen
North Carolina
$9.47M +$4.39M +29,735 +87%
MLL
327
Moody Lynn & Lieberson
Massachusetts
$9.45M -$311K -2,107 -3%
OPCM
328
Osborne Partners Capital Management
California
$9.45M -$660K -4,470 -7%
EBSAM
329
Eubel Brady & Suttman Asset Management
Ohio
$9.35M -$272K -1,840 -3%
LCS
330
Levin Capital Strategies
New York
$9.34M -$409K -2,770 -4%
SRC
331
Shufro Rose & Co
New York
$9.23M -$1.19M -8,046 -11%
AAM
332
Advisors Asset Management
Colorado
$9.15M +$951K +6,443 +12%
PAM
333
Panagora Asset Management
Massachusetts
$9.1M +$3.36M +22,759 +59%
DG
334
Davidson & Garrard
Virginia
$9.06M -$174K -1,180 -2%
Baird Financial Group
335
Baird Financial Group
Wisconsin
$8.99M +$25.7K +174 +0.3%
HC
336
Henshaw Capital
Massachusetts
$8.87M
DILH
337
Dai-ichi Life Holdings
Japan
$8.83M -$1.99M -13,507 -18%
KPCM
338
Kings Point Capital Management
New York
$8.75M -$472K -3,201 -5%
Mitsubishi UFJ Asset Management
339
Mitsubishi UFJ Asset Management
Japan
$8.75M +$177K +1,197 +2%
GHA
340
GW Henssler & Associates
Georgia
$8.72M -$731K -4,955 -8%
UB
341
UMB Bank
Missouri
$8.6M -$287K -1,946 -3%
KKRC
342
Kohlberg Kravis Roberts & Co
New York
$8.59M +$8.58M +58,139 New
PPCM
343
Pillar Pacific Capital Management
California
$8.56M +$25.5K +173 +0.3%
Jones Financial Companies
344
Jones Financial Companies
Missouri
$8.52M -$304K -2,061 -3%
MCA
345
Morris Capital Advisors
Pennsylvania
$8.47M +$1.25M +8,482 +17%
LIC
346
Lodestar Investment Counsel
Illinois
$8.44M +$322K +2,180 +4%
RWM
347
RKL Wealth Management
Pennsylvania
$8.4M -$226K -1,531 -3%
EOJOAM
348
E. Ohman J:or Asset Management
Sweden
$8.37M +$2.04M +13,854 +32%
CTA
349
Chesley Taft & Associates
Illinois
$8.27M -$6.35K -43 -0.1%
QIM
350
Quantitative Investment Management
Virginia
$8.26M +$4.99M +33,800 +153%

TMO Hedge Fund Activity: Q2 2016 in Review

1,055 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2016, worth a combined $51.5B — up 5.3% from $48.9B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new TMO positions and 38 closed out — a net gain of 41 holders — while 384 added to existing stakes and 421 trimmed.

The largest buyer was Sound Shore Management, adding an estimated $180M. The largest seller was Royal London Asset Management, cutting an estimated $2.01B.

  • 1,055 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2016, up from 1,024 in Q1 2016.
  • Funds reported $51.5B of Thermo Fisher Scientific stock for Q2 2016, up 5.3% quarter-over-quarter.
  • 79 funds opened new Thermo Fisher Scientific positions in Q2 2016 and 38 closed out, a net change of +41 holders.
  • The largest Thermo Fisher Scientific buyer in Q2 2016 was Sound Shore Management, an estimated $180M added.
  • The largest Thermo Fisher Scientific seller in Q2 2016 was Royal London Asset Management, an estimated $2.01B sold.

Based on aggregated 13F filings for Q2 2016.